Dale Muzzey, Ph.D., is a distinguished scientist and the Chief Scientific Officer at Myriad Genetics Inc., a leading precision medicine company. With an impressive academic background, Dr. Muzzey earned his Ph.D. in Biophysics from Harvard University, where his research focused on the mechanisms of gene regulation and genome stability. His expertise in these areas has been pivotal in his career, leading him to hold several key positions in the biotechnology industry before joining Myriad Genetics. At Myriad Genetics, Dr. Muzzey plays a crucial role in driving the company's scientific strategy and innovation. He oversees the development and advancement of Myriad's portfolio of diagnostic and therapeutic products, ensuring that they meet the highest standards of quality and efficacy. Under his leadership, Myriad has continued to expand its offerings in oncology, neurology, and autoimmune diseases, solidifying its position as a leader in personalized medicine. Dr. Muzzey's contributions have been instrumental in the company's success, and his vision for the future of precision medicine continues to inspire and guide Myriad's research and development efforts.